Privia Health Group Inc (PRVA) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Privia Health Group Inc stock (PRVA) is currently trading at $21.03. Privia Health Group Inc PE ratio is 118.00. Privia Health Group Inc PS ratio (Price-to-Sales) is 1.24. Analyst consensus price target for PRVA is $31.85. WallStSmart rates PRVA as Underperform.
- PRVA PE ratio analysis and historical PE chart
- PRVA PS ratio (Price-to-Sales) history and trend
- PRVA intrinsic value — DCF, Graham Number, EPV models
- PRVA stock price prediction 2025 2026 2027 2028 2029 2030
- PRVA fair value vs current price
- PRVA insider transactions and insider buying
- Is PRVA undervalued or overvalued?
- Privia Health Group Inc financial analysis — revenue, earnings, cash flow
- PRVA Piotroski F-Score and Altman Z-Score
- PRVA analyst price target and Smart Rating
Privia Health Group Inc
📊 No data available
Try selecting a different time range
PRVA Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Privia Health Group Inc (PRVA)
PRVA trades 157% above its Graham fair value of $8.42, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Privia Health Group Inc (PRVA) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, eps growth, institutional own.. Concerns around return on equity and operating margin. Mixed signals suggest waiting for clearer direction before acting.
Privia Health Group Inc (PRVA) Key Strengths (4)
Earnings per share surging 132.80% year-over-year
99.11% of shares held by major funds and institutions
Paying $1.24 for every $1 of annual revenue
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
Privia Health Group Inc (PRVA) Areas to Watch (5)
Very low returns on shareholder equity
Near-zero operating margins, business under pressure
Very thin margins, barely profitable
Premium pricing at 3.6x book value
Solid revenue growth at 17.40% per year
Supporting Valuation Data
Privia Health Group Inc (PRVA) Detailed Analysis Report
Overall Assessment
This company scores 48/100 in our Smart Analysis, earning a D+ grade. Out of 9 metrics analyzed, 4 register as strengths (avg 8.8/10) while 5 fall into concern territory (avg 2.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on EPS Growth, Institutional Own., Price/Sales. Valuation metrics including Price/Sales (1.24) suggest the stock is attractively priced. Growth metrics are encouraging with EPS Growth at 132.80%.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Profit Margin. Some valuation metrics including Price/Book (3.56) suggest expensive pricing. Growth concerns include Revenue Growth at 17.40%, which may limit upside. Profitability pressure is visible in Return on Equity at 4.03%, Operating Margin at 2.08%, Profit Margin at 1.08%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 4.03% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 17.40% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
PRVA Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
PRVA's Price-to-Sales ratio of 1.24x sits near its historical average of 1.32x (0th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 11% below its historical high of 1.39x set in Mar 2026, and 0% above its historical low of 1.24x in Mar 2026.
Compare PRVA with Competitors
Top HEALTH INFORMATION SERVICES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Privia Health Group Inc (PRVA) · HEALTHCARE › HEALTH INFORMATION SERVICES
The Big Picture
Privia Health Group Inc is a strong growth company balancing expansion with improving profitability. Revenue reached 2.1B with 17% growth year-over-year. Profit margins are strong at 108.0%, reflecting pricing power and operational efficiency.
Key Findings
ROE of 403.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Profit margin of 108.0% and operating margin of 208.0% demonstrate strong pricing power and operational efficiency.
What to Watch Next
Valuation compression risk at a P/E of 118.0x. Any growth miss could trigger a sharp correction.
Sector dynamics: monitor HEALTH INFORMATION SERVICES industry trends, competitive moves, and regulatory changes that could impact Privia Health Group Inc.
Bottom Line
Privia Health Group Inc offers an attractive blend of growth (17% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Privia Health Group Inc(PRVA)
NASDAQ
HEALTHCARE
HEALTH INFORMATION SERVICES
USA
Privia Health Group, Inc. is a population health technology and medical practice management company in the United States.